Medicine and Dentistry
Patient
100%
Ganglioneuroblastoma
87%
Acute Lymphoblastic Leukemia
72%
Combination Therapy
58%
Cells
53%
Child
36%
Therapeutic Procedure
32%
Malignant Neoplasm
31%
P16
30%
Dinutuximab
29%
Gene
27%
Neoplasm
27%
Antibody
24%
In Vitro
24%
Oncology
24%
Toxicity
21%
Breast Cancer
20%
Granulocyte Macrophage Colony Stimulating Factor
20%
Disease
20%
Inpatient
19%
Childhood
19%
Immunotherapy
17%
Diagnosis
17%
5' Methylthioadenosine Phosphorylase
17%
Leukemia Cell
17%
Cancer
16%
Survival
16%
Childhood Cancer
16%
Glycan
16%
Tissues
15%
Leukemia
15%
Event Free Survival
15%
Programmed Cell Death
14%
Analysis
14%
Glycolipid
14%
Monoclonal Antibody
13%
Stem Cell
13%
Cancer Cell
13%
T Cell
13%
Protein P53
13%
Overall Survival
13%
Cancer Stem Cell
12%
Chemotherapeutic Agent
10%
Isotretinoin
10%
Lymphocyte
10%
Prognosis
10%
Development
10%
Monocyte
10%
Allodynia
9%
Drug
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
42%
Nested Gene
39%
Protein
36%
P16
30%
Synthesis
26%
Cancer Stem Cell
26%
Mouse
25%
Glycolipid
23%
Antibody
23%
GD2
20%
Sample
19%
DNA
19%
Monoclonal Antibody
18%
Natural Killer T Cell
17%
Phosphorylase
17%
Glycosphingolipid
17%
Development
16%
Embryonic Stem Cell
16%
Survival
14%
Surface Property
14%
Ceramide
14%
Regulatory Mechanism
14%
Overall Survival
13%
MicroRNA
12%
Growth
12%
Activin
12%
Peptide
11%
Angiogenesis
10%
Granulocyte Macrophage Colony-Stimulating Factor
10%
Zebra Fish
10%
Cell Cycle
10%
Bone
10%
Lysozyme
10%
Deoxyadenosine
10%
Carbohydrate
10%
Messenger RNA
10%
Stage Specific Embryonic Antigen 3
10%
Mutation
9%
Phosphorylation
9%
Microarray
9%
FUT1
9%
Event Free Survival
9%
Interleukin 2
9%
Phase I Trials
8%
Genotyping
8%
Anticancer
8%
Cell Migration
8%
P53
8%
Cancer Immunotherapy
7%
Ganglioside
7%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
50%
Neuroblastoma
39%
Dinutuximab
32%
Immunotherapy
27%
Neoplasm
27%
Breast Cancer
22%
Antibody
22%
Acute Lymphoblastic Leukemia
20%
Pentostatin
20%
Toxicity
19%
Glycolipid
15%
Mouse
15%
Apoptosis
15%
Deoxyadenosine
14%
Protein
13%
Granulocyte Macrophage Colony Stimulating Factor
12%
Vaccine
12%
Leukemia
10%
Event Free Survival
10%
Drug
10%
Monoclonal Antibody
10%
Diseases
10%
DNA
10%
Cytotoxicity
9%
Glycan
9%
Cytokine
9%
Isotretinoin
9%
Childhood Cancer
8%
Irinotecan
8%
Overall Survival
8%
Glycosphingolipid
8%
Galactose
8%
Anticarcinogen
7%
Ligand
7%
Survival
7%
Killer Cell Immunoglobulin Like Receptor
7%
Solid Malignant Neoplasm
6%
RNA
6%
Xanthone Derivative
6%
Garcinia
6%
Osteosarcoma
6%
Chemotherapy
6%
Ganglioside GD2
5%
Polysaccharide
5%
Zebra Fish
5%
Chimeric Antibody
5%
Metastatic Breast Cancer
5%
microRNA
5%
Pharmacokinetics
5%
Nanodiamond
5%